Mr Paul Anderson
Clinical Sub-Dean
Department of Medical Education
99 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
The CAMUS Initiative: A Multiphase, Multicentre International Collaboration to Redefine Risk Stratification, Reporting, and Grading of Surgical Complications in Urology
DOI: 10.1016/j.euros.2026.01.0122026
Journal article
Safety and Efficacy of Extracorporeal Shock Wave Therapy for the Management of Chronic Pelvic Pain Syndrome: A Systematic Review
DOI: 10.1016/j.urology.2026.01.0152026
Journal article
A0086 BCG plus mitomycin (BCG MM) versus BCG-alone as adjuvant intravesical therapy for high-risk, Non-Muscle-Invasive Bladder Cancer (NMIBC): Effects on urinary symptoms and other aspects of Health-Related Quality of Life (HRQL) in a randomised trial (BCGMM, ANZUP 1301)
DOI: 10.1016/s0302-2838(26)00151-x2026
Journal article
Is it time to break the habit of treating preoperative asymptomatic bacteriuria?
DOI: 10.1111/bju.700862026
Journal article
Bacillus Calmette-Guérin Plus Mitomycin Versus Bacillus Calmette-Guérin Alone for Bacillus Calmette-Guérin–naïve Non–muscle-invasive Bladder Cancer: A Randomised Phase 3 Trial (ANZUP 1301)
DOI: 10.1016/j.eururo.2026.01.0092025
Journal article
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment
DOI: 10.1111/bju.167272025
Journal article
Mitomycin plus BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: A randomized phase 3 trial (ANZUP 1301).
DOI: 10.1200/jco.2025.43.17_suppl.lba4504
RECENT SCHOLARLY WORKS
2025
Journal article
PD08-12 36-MONTH OUTCOMES FROM THE ZEST PILOT STUDIES OF THE ZENFLOW SPRING SYSTEM FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA (BPH)
DOI: 10.1097/01.ju.0001109800.53897.68.122025
Journal article
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SI
DOI: 10.1186/s41687-025-00864-72024
Journal article
WATER versus WATER II 5-year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80-cm3 and 80–150-cm3 prostates
DOI: 10.1002/bco2.430